- Home
- SLS vs SSSS Comparison
SLS vs SSSS Comparison
Compare SLS & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- SSSS
- Stock Information
- Founded
- SLS 2012
- SSSS 2010
- Country
- SLS United States
- SSSS United States
- Employees
- SLS N/A
- SSSS N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- SSSS Finance: Consumer Services
- Sector
- SLS Health Care
- SSSS Finance
- Exchange
- SLS Nasdaq
- SSSS Nasdaq
- Market Cap
- SLS 165.6M
- SSSS 138.2M
- IPO Year
- SLS N/A
- SSSS N/A
- Fundamental
- Price
- SLS $1.91
- SSSS $8.73
- Analyst Decision
- SLS Strong Buy
- SSSS Strong Buy
- Analyst Count
- SLS 1
- SSSS 4
- Target Price
- SLS $7.00
- SSSS $9.50
- AVG Volume (30 Days)
- SLS 1.8M
- SSSS 255.3K
- Earning Date
- SLS 08-12-2025
- SSSS 08-06-2025
- Dividend Yield
- SLS N/A
- SSSS 11.44%
- EPS Growth
- SLS N/A
- SSSS N/A
- EPS
- SLS N/A
- SSSS 2.22
- Revenue
- SLS N/A
- SSSS $2,784,381.00
- Revenue This Year
- SLS N/A
- SSSS $6.95
- Revenue Next Year
- SLS N/A
- SSSS N/A
- P/E Ratio
- SLS N/A
- SSSS $3.94
- Revenue Growth
- SLS N/A
- SSSS N/A
- 52 Week Low
- SLS $0.77
- SSSS $3.75
- 52 Week High
- SLS $2.27
- SSSS $9.12
- Technical
- Relative Strength Index (RSI)
- SLS 60.77
- SSSS 57.61
- Support Level
- SLS $1.50
- SSSS $8.28
- Resistance Level
- SLS $1.77
- SSSS $8.55
- Average True Range (ATR)
- SLS 0.11
- SSSS 0.27
- MACD
- SLS 0.04
- SSSS 0.00
- Stochastic Oscillator
- SLS 97.62
- SSSS 78.48
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.